Cargando…

Feasibility, and barriers to use escitalopram in functional gastrointestinal disorders

Background and study aims: The feasibility and barriars of escitalopram use in patients with functional gastrointestinal disorders (FGIDs) are still debated. We aimed to evaluate the feasibility, safety and efficacy and barriars of escitalopram use in managing FGIDs in the Saudi population. Patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alkhowaiter, Saad S., Alshahrani, Amani H., Almarzouqi, Hala F., Alonazi, Gadah K., Alhawassi, Tariq M., AlRasheed, Maha M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240913/ https://www.ncbi.nlm.nih.gov/pubmed/37284319 http://dx.doi.org/10.3389/fphar.2023.1131354

Ejemplares similares

Assessment of Knowledge, Attitude, and Practice of Security and Safety Workers Toward the COVID-19 Pandemic: A Cross-Sectional Study
por: AlRasheed, Maha M., et al.
Publicado: (2021)

Genetic Insights into the Middle East Respiratory Syndrome Coronavirus Infection among Saudi People
por: Abuelizz, Hatem A., et al.
Publicado: (2021)

Knowledge and willingness of physicians about deprescribing among older patients: a qualitative study
por: AlRasheed, Maha M, et al.
Publicado: (2018)

Knowledge, Attitude, and Practice Towards COVID-19 Among Pharmacists: A Cross-Sectional Study
por: AlRasheed, Maha M, et al.
Publicado: (2021)

Impact of Vortioxetine on Synaptic Integration in Prefrontal-Subcortical Circuits: Comparisons with Escitalopram
por: Chakroborty, Shreaya, et al.
Publicado: (2017)

Encapsulated Escitalopram and Paroxetine Intranasal Co-Administration: In Vitro/In Vivo Evaluation
por: Silva, Soraia, et al.
Publicado: (2021)

Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders
por: Aldrich, Stacey L., et al.
Publicado: (2019)

Quality of Life, Fatigue, and Physical Symptoms Post-COVID-19 Condition: A Cross-Sectional Comparative Study
por: AlRasheed, Maha M., et al.
Publicado: (2023)

Population pharmacokinetics model for escitalopram in Chinese psychiatric patients: effect of CYP2C19 and age
por: Liu, Shujing, et al.
Publicado: (2022)

Gene Therapy Knowledge and Attitude Among Healthcare Professionals: A Cross-Sectional Study
por: AlRasheed, Maha M., et al.
Publicado: (2021)

TSH-β gene polymorphism in Saudi patients with thyroid cancer: A case-control study
por: AlRasheed, Maha M.
Publicado: (2022)

Tele-pharmacy Anticoagulation Clinic During COVID-19 Pandemic: Patient Outcomes
por: Al Ammari, Maha, et al.
Publicado: (2021)

CYP2C19 Genotyping May Provide a Better Treatment Strategy when Administering Escitalopram in Chinese Population
por: Huang, Xinyi, et al.
Publicado: (2021)

Bilateral acute closed angle glaucoma associated with the discontinuation of escitalopram: a case report
por: AlQuorain, Sara, et al.
Publicado: (2016)

Evaluation of the role of CDKN2B gene in type 2 diabetes mellitus and hypertension in ethnic Saudi Arabs
por: AlRasheed, Maha Meshal
Publicado: (2018)

Acute 5-HT(2C) Receptor Antagonist SB-242084 Treatment Affects EEG Gamma Band Activity Similarly to Chronic Escitalopram
por: Papp, Noémi, et al.
Publicado: (2020)

Escitalopram Ameliorates Cardiomyopathy in Type 2 Diabetic Rats via Modulation of Receptor for Advanced Glycation End Products and Its Downstream Signaling Cascades
por: Ahmed, Lamiaa A., et al.
Publicado: (2020)

Escitalopram in patients with psoriasis
por: Artemieva, M., et al.
Publicado: (2021)

Vaccinations against respiratory infections in Arabian Gulf countries: Barriers and motivators
por: Alqahtani, Amani S, et al.
Publicado: (2017)

Prevalence, prescribing and barriers to effective management of hypertension in older populations: a narrative review
por: Alhawassi, Tariq M, et al.
Publicado: (2015)

Preparation, Evaluation and Bioavailability Studies of Eudragit Coated PLGA Nanoparticles for Sustained Release of Eluxadoline for the Treatment of Irritable Bowel Syndrome
por: Anwer, Md. K., et al.
Publicado: (2017)

Polypharmacy among patients with diabetes: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia
por: Alwhaibi, Monira, et al.
Publicado: (2018)

Eosinophilic Esophagitis in a 75-Year-Old Saudi Man: A Case Report
por: Alkhowaiter, Saad S
Publicado: (2023)

Escitalopram induced mania
por: Parker, Shubangi, et al.
Publicado: (2007)

Escitalopram Induced Angioedema
por: Conde, Samantha L, et al.
Publicado: (2022)

Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders
por: Singh, Rajan, et al.
Publicado: (2022)

An emerging role for escitalopram in the treatment of obsessive-compulsive disorder
por: Hedges, Dawson W, et al.
Publicado: (2007)

Resistant social anxiety disorder response to Escitalopram
por: Pallanti, Stefano, et al.
Publicado: (2006)

The therapeutic potential of escitalopram in the treatment of panic disorder
por: Townsend, Mark H, et al.
Publicado: (2007)

Reproducibility of the Efficacy of Escitalopram in Patients with Major Depression Who Had Previously Remitted with Escitalopram
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Escitalopram-induced epistaxis: A case report
por: AlJhani, Sumayah A.
Publicado: (2021)

Interaction between escitalopram and risperidone
por: Rao, Pradeep, et al.
Publicado: (2005)

Severe hyponatremia associated with escitalopram
por: Rawal, Gautam, et al.
Publicado: (2017)

Escitalopram-induced extrapyramidal symptoms
por: Kumar, Pattath Narayanan Suresh, et al.
Publicado: (2019)

Rise of escitalopram and the fall of citalopram
por: Cavanah, Luke R., et al.
Publicado: (2023)

Therapeutic role of Wuda granule in gastrointestinal motility disorder through promoting gastrointestinal motility and decreasing inflammatory level
por: Jiang, Zhi, et al.
Publicado: (2023)

Impact of Opioid Consumption in Patients With Functional Gastrointestinal Disorders
por: Melchior, Chloé, et al.
Publicado: (2020)

Current use of complementary and conventional medicine for treatment of pediatric patients with gastrointestinal disorders
por: Sayre, Casey L., et al.
Publicado: (2023)

Unraveling the Potential of Isorhamnetin as an Adjuvant in Depression Treatment with Escitalopram
por: Gammoh, Omar, et al.
Publicado: (2023)

Comparative efficacy of escitalopram in the treatment of major depressive disorder
por: Ali, Mazen K, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_bmndr51spopaa18m3ctc2gsvs4